FTC sues key pharmacy advantage managers over insulin costs The agency brought action versus Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the record cost of everyday living-saving insulin medications. The deal needs to be finished by Sept. 30 or customers can terminate https://ayahealthcareaddress95162.webbuzzfeed.com/31170009/the-smart-trick-of-healthcare-news-that-no-one-is-discussing